Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system

Journal of Virological Methods

Volumn 148, Issue 1-2, 2008, Pages 48-57

  Broccolo, Francesco ^a   Cocuzza, Clementina E ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Automated extraction; HPV; Quantitation; Real time PCR; Viral load

Indexed keywords

NUCLEIC ACID;

ARTICLE; CONTROLLED STUDY; DNA TEMPLATE; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 67; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX DISEASE; VIRUS LOAD; WART VIRUS;

AUTOMATION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL DISEASES;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 39049172036     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.10.003     Document Type: Article

References (23)

1. Beskow A.H., and Gyllensten U.B. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int. J. Cancer 101 (2002) 526-531
2. Broccolo F., Drago F., Careddu A.M., Foglieni C., Turbino L., Cocuzza C.E., Gemetti C., Lusso P., Rebora A.E., and Malnati M.S. Additional evidence that Pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J. Invest. Dermatol. 124 (2005) 1234-1240
3. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collina R.J., Zuna R.E., Dunn S.T., Chu T.Y., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Martins C.R., Sanchez G.I., Bosch F.X., Munoz N., and Bernard H.U. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 79 (2005) 13630-13640
4. Gravitt P.E., Peyton C., Wheeler C., Apple R., Higuchi R., and Shah K.V. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J. Virol. Methods 112 (2003) 23-33
5. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
6. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338 (1998) 423-428
7. Jacobs M.V., de Roda, Husman A.M., van den Brule A.J., Snijders P.J., Meijer C.J., and Walboomers J.M. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol. 33 (1995) 901-905
8. Jacobs M.V., Walboomers J.M., Snijders P.J., Voorhorst F.J., Verheijen R.H., Fransen-Daalmeijer N., and Meijer C.J. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int. J. Cancer 15 (2000) 221-227
9. Josefsson A., Livak K., and Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J. Clin. Microbiol. 37 (1999) 490-496
10. Josefsson A.M., Magnusson P.K., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Andersen P.K., Melbye M., Adami H.O., and Gyllensten U.B. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
11. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L., Suntum M., Bock J.E., Poll P.A., and Meijer C.J. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. B. M. J. 325 (2002) 572
12. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., Lindeman J., ter Harmsel B., Burger M., and Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37 (1999) 2508-2517
13. Lorincz A.T., Castle P.E., Sherman M.E., Scott D.R., Glass A.G., Wacholder S., Rush B.B., Gravitt P.E., Schussler J.E., and Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360 (2002) 228-229
14. Moberg M., Gustavsson I., and Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int. J. Cancer 112 (2004) 854-859
15. Nagao S., Yoshinouchi M., Miyagi Y., Hongo A., Kodama J., Itoh S., and Kudo T. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J. Clin. Microbiol. 40 (2002) 863-867
16. Peitsaro P., Johansson B., and Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40 (2002) 886-891
17. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., and Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35 (1997) 1304-1310
18. Rouet F., Ekouevi D.K., Chaix M.L., Burgard M., Inwoley A., Tony T.D., Danel C., Anglaret X., Leroy V., Msellati P., Dabis F., and Rouzioux C. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43 (2005) 2709-2717
19. Swan D.C., Tucker R.A., Holloway B.P., and Icenogle J.P. A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA. J. Clin. Microbiol. 35 (1997) 886-891
20. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R., Nisenbaum R.A., Reeves W.C., and Icenogle J.P. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37 (1999) 1030-1034
21. Woodman C.B., Collina S.I., and Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7 (2007) 11-22 (Review)
22. Ylitalo N., Josefsson A., Melbye M., Sorensen P., Frisch M., Andersen P.K., Sparen P., Gustafsson M., Magnusson P., Ponten J., Gyllensten U., and Adami H.O. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res. 60 (2000) 6027-6032
23. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350 (Review)